Quality of Life in Women with Polycystic Ovary Syndrome after a Program of Resistance Exercise Training

Ramos, Fabiene K. Picchi; Lara, Lúcia Alves da Silva; Kogure, Gislaine Satyko; Silva, Rafael Costa; Ferriani, Rui Alberto; Silva de Sá, Marcos Felipe; Reis, Rosana Maria dos

doi:10.1055/s-0036-1585457

Acessibilidade / Reportar erro

Brasil

Revista Brasileira de Ginecologia e Obstetrícia

Español English

Brasil

Español English

sumário « anterior atual seguinte »

Sumário

Original Article • Rev. Bras. Ginecol. Obstet. 38 (07) • July 2016 • https://doi.org/10.1055/s-0036-1585457 copy

Quality of Life in Women with Polycystic Ovary Syndrome after a Program of Resistance Exercise Training

Qualidade de vida emmulheres com síndrome de ovários policísticos após um programa de treinamento de exercício resistido

Authorship SCIMAGO INSTITUTIONS RANKINGS

Abstract

Purpose

Aerobic exercises may improve quality of life (QoL) in women with polycystic ovary syndrome (PCOS). However, there is no data on the effect of resistance exercise training (RET) programs on the QoL of women with PCOS. Thus, this study aimed to assess the effect of a 16-week RET program on QoL in PCOS women.

Methods

This 16-week case-control study enrolled 43 women with PCOS (PCOS group, PCOSG) and 51 healthy pre-menopausal controls aged 18 to 37 years (control group, CG). All women underwent a supervised RET program for 16 weeks, and were evaluated in two different occasions: week-0 (baseline), and week-16 (after RET). Quality of life was assessed using the 36-Item Short Form Health Survey (SF-36).

Results

Testosterone reduced significantly in both groups after RET (p < 0.01). The PCOSG had improvements in functional capacity at week-16 relative to week-0 (p = 0.02). The CG had significant improvements in vitality, social aspects, and mental health at week-16 relative to week-0 (p ≤ 0.01). There was a weak correlation between social aspects of the SF-36 domain and testosterone levels in PCOS women.

Conclusion

A 16-week RET program modestly improved QoL in women with PCOS.

Keywords:
strength training; polycystic ovarian syndrome; exercise therapy; aerobic exercise

Variable	PCOS (N= 43)	Control (N= 51)	p
Variable	Mean ± SD(range)	Mean ± SD(range)
Age (years)	27.8 ± 5.34(18.33–37.77)	29.74 ± 5.26(19.28–37.76)	0.08
Height (m)	1.60 ± 0.05(1.46–1.68)	1.61 ± 0.06(1.48–1.75)	0.52
Weight (kg)	71.65 ± 14.3(50.7–104.6)	67.39 ± 14.71(46.5–110)	0.15
BMI (kg/m²)	27.91 ± 5.51(19.83–38.42)	25.99 ± 5.49(18.07–39.44)	0.08
Waist circumference (cm)	80.59 ± 11.87(76.94–109.5)	75.86 ± 11.19(59–108)	0.10
Testosterone (ng/dL)	88.93 ± 34.73(30–182)	73.94 ± 29.4(32–172)	0.02
Androstenedione (ng/mL)	120.3 ± 43.29(34.6–242.5)	98.48 ± 32.78(42–168.8)	0.02
Glucose (mmol/L)	96.31 ± 16.84(73–131)	95.8 ± 17.75(70–146)	0.53
Insulin (mU/L)	8.54 ± 6.07(1–24.8)	5.2 ± 4.52(1–32.9)	0.001
HOMA-IR	2.11 ± 1.79(0.2–10.55)	1.25 ± 1.25(0.18–7.53)	0.006

Variable	Wk-0	Wk-16	Wk-0 versus Wk-16
	Mean ± SD(range)	Mean ± SD(range)	p
Weight (kg)	71.65 ± 14.3(58.5–104.6)	71.08 ± 13.27(51.4–105)	0.14
BMI (kg/m²)	27.91 ± 5.51(19.83–38.42)	27.68 ± 5.06(19.83–38.57)	0.12
Waist circumference (cm)	80.59 ± 11.87(64–109.5)	79.35 ± 10.54(64.5–105)	< 0.01

Variable	PCOS group			Control group
	Wk-0	Wk-16	Wk-0 versus Wk-16	Wk-0	Wk-16	Wk-0 versus Wk 16
	Mean ± SD(range)	Mean ± SD(range)	p	Mean ± SD(range)	Mean ± SD(range)	p
Functional Capacity	86.86 ± 13(60–100)	91.74 ± 11.44(60–100)	0.02	87.25 ± 13.43(50–100)	90.39 ± 10.76(60–100)	0.10
Limitations of Physical Aspects	75.58 ± 26.44(0–100)	84.3 ± 27.29(0–100)	0.08	77.94 ± 31.48(0–100)	79.41 ± 24.85(0–100)	0.75
Pain	68.63 ± 23.17(12–100)	74.3 ± 20.09(10–100)	0.16	67.61 ± 21.61(12–100)	71.12 ± 24.38(20–100)	0.34
General Health Status	58.49 ± 17.79(17–87)	62.7 ± 20.15(17–100)	0.27	70.61 ± 20.83(12–100)	73.78 ± 18.67(27–100)	0.37
Vitality	59.53 ± 18.45(25–90)	64.42 ± 18.65(20–90)	0.08	65.49 ± 19.60(25–100)	75.29 ± 19.43(30–100)	<0.01
Social Aspects	76.16 ± 24.82(25–100)	80.93 ± 18.14(37.5–100)	0.26	75 ± 24.62(25–100)	84.56 ± 17.96(37.5–100)	0.01
Emotional Aspects	72.84 ± 31.09(0–100)	73.62 ± 28.71(0–100)	0.90	69.26 ± 38.79(0–100)	80.37 ± 29.96(0–100)	0.06
Mental Health	68.42 ± 23.92(12–100)	72.93 ± 19.94(12–96)	0.26	68.2 ± 20.52(20–96)	77.59 ± 14.63(32–100)	0.01

Federação Brasileira das Sociedades de Ginecologia e Obstetrícia Av. Brigadeiro Luís Antônio, 3421, sala 903 - Jardim Paulista, 01401-001 São Paulo SP - Brasil, Tel. (55 11) 5573-4919 - Rio de Janeiro - RJ - Brazil
E-mail: editorial.office@febrasgo.org.br

Acompanhe os números deste periódico no seu leitor de RSS

[1] Address for correspondence Rosana Maria Reis, MD, PhD, Professor, Setor de Reprodução Humana, Departamento de Ginecologia e Obstetrícia, Faculdade deMedicina de Ribeirão Preto, Universidade de São Paulo, Av. Bandeirantes, 3900, 14049-900, Ribeirão Preto, SP, Brazil (e-mail: romareis@fmrp.usp.br).